Living bio-drug therapies using mesenchymal stem cells and exosomes for mechanically ventilated patients with acute respiratory distress syndrome: A systematic review and meta-analysis
MSC and exosome-based therapies were found to be safe and associated with a reduced duration of mechanical ventilation in patients with ARDS. NMA showed that exosome-based therapy matched the benefits of its parent cells, but with practical and logistical advantages.
Authors
- Nasser Alrashidi
- Khawaja Husnain Haider (ORCID: https://orcid.org/0000-0002-7907-4808)
- Mariam Safwan Bourgleh
- Moaz Safwan
- Abdulsalam Al-Ruqi
- Omran Shrebaty (ORCID: https://orcid.org/0009-0006-3403-9562)
- Faisal Almujaydil
- Basel AlOthaim
Institutions
- Sulaiman Al Rajhi Colleges (SA)
Publication Details
- Journal
- World Journal of Stem Cells
- Published
- 2025-10-24
- DOI
- https://doi.org/10.4252/wjsc.v17.i10.111978
- Primary Topic
- Respiratory Support and Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00